accountexcluding items, vs. $0.69/shr forecast * Shares rise 1.2 percent NEW YORK, Oct 29 (Reuters) - Allergan Inc (AGN.N) on Thursday said its quarterly profit rose, as sales of anti-wrinkle drug Botox rebounded from an earlier slump and helped offset lower...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Allergan profit rises, Botox rebounds
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
